Jurriaans S - Search Results

1

High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.

Kostense S, Ogg GS, Manting EH, Gillespie G, Joling J, Vandenberghe K, Veenhof EZ, van Baarle D, Jurriaans S, Klein MR, Miedema F. Kostense S, et al. Among authors: jurriaans s. Eur J Immunol. 2001 Mar;31(3):677-86. doi: 10.1002/1521-4141(200103)31:3<677::aid-immu677>3.0.co;2-m. Eur J Immunol. 2001. PMID: 11241270 Free article.

2

Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.

Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, De Wit S, Dabis F, Pradier C, d'Arminio Monforte A, Kovari H, Law M, Lundgren JD, Sabin CA; Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group. Hatleberg CI, et al. J Int AIDS Soc. 2018 Mar;21(3):e25083. doi: 10.1002/jia2.25083. J Int AIDS Soc. 2018. PMID: 29509305 Free PMC article.

3

Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration.

Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study. Tusch E, et al. Clin Infect Dis. 2024 Nov 22;79(5):1242-1257. doi: 10.1093/cid/ciae228. Clin Infect Dis. 2024. PMID: 38663013

4

External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.

Surial B, Ramírez Mena A, Roumet M, Limacher A, Smit C, Leleux O, Mocroft A, van der Valk M, Bonnet F, Peters L, Rockstroh JK, Günthard HF, Berzigotti A, Rauch A, Wandeler G; Swiss HIV Cohort Study; ATHENA Observational Cohort Study; EuroSIDA; ANRS CO3 Aquitaine Cohort. Surial B, et al. J Hepatol. 2023 May;78(5):947-957. doi: 10.1016/j.jhep.2022.12.029. Epub 2023 Jan 21. J Hepatol. 2023. PMID: 36690280 Free article.

5

Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.

Hogervorst E, Jurriaans S, de Wolf F, van Wijk A, Wiersma A, Valk M, Roos M, van Gemen B, Coutinho R, Miedema F, et al. Hogervorst E, et al. Among authors: jurriaans s. J Infect Dis. 1995 Apr;171(4):811-21. doi: 10.1093/infdis/171.4.811. J Infect Dis. 1995. PMID: 7706807

6

Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo.

Jurriaans S, de Ronde A, Dekker J, Cornelissen M, Goudsmit J. Jurriaans S, et al. J Med Virol. 1995 Jan;45(1):91-8. doi: 10.1002/jmv.1890450117. J Med Virol. 1995. PMID: 7714497

7

Fluctuations in steady state level of genomic HIV-1 RNA and replication intermediates related to disease progression rate.

Jurriaans S, Goudsmit J. Jurriaans S, et al. Immunol Lett. 1996 Jun;51(1-2):15-22. doi: 10.1016/0165-2478(96)02549-7. Immunol Lett. 1996. PMID: 8811339

8

In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro.

Maas JJ, Roos MT, Keet IP, Mensen EA, Krol A, Veenstra J, Schellekens PT, Jurriaans S, Coutinho RA, Miedema F. Maas JJ, et al. Among authors: jurriaans s. J Infect Dis. 1998 Oct;178(4):1024-9. doi: 10.1086/515655. J Infect Dis. 1998. PMID: 9806030

9

Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression.

Ogg GS, Kostense S, Klein MR, Jurriaans S, Hamann D, McMichael AJ, Miedema F. Ogg GS, et al. Among authors: jurriaans s. J Virol. 1999 Nov;73(11):9153-60. doi: 10.1128/JVI.73.11.9153-9160.1999. J Virol. 1999. PMID: 10516022 Free PMC article.

10

OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.

van Praag RM, Prins JM, Roos MT, Schellekens PT, Ten Berge IJ, Yong SL, Schuitemaker H, Eerenberg AJ, Jurriaans S, de Wolf F, Fox CH, Goudsmit J, Miedema F, Lange JM. van Praag RM, et al. Among authors: jurriaans s. J Clin Immunol. 2001 May;21(3):218-26. doi: 10.1023/a:1011091300321. J Clin Immunol. 2001. PMID: 11403229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters